Childhood Cancer of Unknown Primary (CUP)
Cancer of Unknown Primary (CUP) in children and adolescents
TREATMENT READING
Source sections for this topic, with the original link and date. Patient and professional reading are labelled separately.
Not medical advice · Not a complete treatment or trial directory
Made by Triangle.
Selected text from the National Cancer Institute, with the original link and date. Made by Triangle. This page is not an NCI PDQ summary. Source topics may be broader than an individual diagnosis.
Source: Childhood Cancer of Unknown Primary (CUP) Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: August 13, 2024. Captured 2026-09-09.
Cancer in children and adolescents is rare, although the overall incidence has slowly increased since 1975.[1] Children and adolescents with cancer should be referred to medical centers that have a multidisciplinary team of cancer specialists with experience treating the cancers that occur during childhood and adolescence. This multidisciplinary team approach incorporates the skills of the following pediatric specialists and others to ensure that children receive treatment, supportive care, and rehabilitation to achieve optimal survival and quality of life:
Sources: 1
Primary care physicians.
Pediatric surgeons.
Pathologists.
Pediatric radiation oncologists.
Pediatric medical oncologists and hematologists.
Ophthalmologists.
Rehabilitation specialists.
Pediatric oncology nurses.
Social workers.
Child-life professionals.
Psychologists.
Nutritionists.
For specific information about supportive care for children and adolescents with cancer, see the summaries on Supportive and Palliative Care.
Sources: Supportive and Palliative Care
The American Academy of Pediatrics has outlined guidelines for pediatric cancer centers and their role in the treatment of children and adolescents with cancer.[2] At these centers, clinical trials are available for most types of cancer that occur in children and adolescents, and the opportunity to participate is offered to most patients and their families. Clinical trials for children and adolescents diagnosed with cancer are generally designed to compare potentially better therapy with current standard therapy. Other types of clinical trials test novel therapies when there is no standard therapy for a cancer diagnosis. Most of the progress in identifying curative therapies for childhood cancers has been achieved through clinical trials. Information about ongoing clinical trials is available from the NCI website.
Sources: 2 · NCI website
Dramatic improvements in survival have been achieved for children and adolescents with cancer. Between 1975 and 2020, childhood cancer mortality decreased by more than 50%.[3-5] Childhood and adolescent cancer survivors require close monitoring because side effects of cancer therapy may persist or develop months or years after treatment. For information about the incidence, type, and monitoring of late effects in childhood and adolescent cancer survivors, see Late Effects of Treatment for Childhood Cancer.
Sources: 3 · 5 · Late Effects of Treatment for Childhood Cancer
Childhood cancer is a rare disease, with about 15,000 cases diagnosed annually in the United States in individuals younger than 20 years.[6] The U.S. Rare Diseases Act of 2002 defines a rare disease as one that affects populations smaller than 200,000 people in the United States. Therefore, all pediatric cancers are considered rare.
Sources: 6 · Rare Diseases Act of 2002
The designation of a rare tumor is not uniform among pediatric and adult groups. In adults, rare cancers are defined as those with an annual incidence of fewer than six cases per 100,000 people. They account for up to 24% of all cancers diagnosed in the European Union and about 20% of all cancers diagnosed in the United States.[7,8] In children and adolescents, the designation of a rare tumor is not uniform among international groups, as follows:
A consensus effort between the European Union Joint Action on Rare Cancers and the European Cooperative Study Group for Rare Pediatric Cancers estimated that 11% of all cancers in patients younger than 20 years could be categorized as very rare. This consensus group defined very rare cancers as those with annual incidences of fewer than two cases per 1 million people. However, three additional histologies (thyroid carcinoma, melanoma, and testicular cancer) with incidences of more than two cases per 1 million people were also included in the very rare group due to a lack of knowledge and expertise in the management of these tumors.[9]
Sources: 9
The Children's Oncology Group defines rare pediatric cancers as those listed in the International Classification of Childhood Cancer subgroup XI, which includes thyroid cancers, melanomas and nonmelanoma skin cancers, and multiple types of carcinomas (e.g., adrenocortical carcinomas, nasopharyngeal carcinomas, and most adult-type carcinomas such as breast cancers and colorectal cancers).[10] These diagnoses account for about 5% of the cancers diagnosed in children aged 0 to 14 years and about 27% of the cancers diagnosed in adolescents aged 15 to 19 years.[4] Most cancers in subgroup XI are either melanomas or thyroid cancers, with other cancer types accounting for only 2% of the cancers diagnosed in children aged 0 to 14 years and 9.3% of the cancers diagnosed in adolescents aged 15 to 19 years.
These rare cancers are extremely challenging to study because of the relatively few patients with any individual diagnosis, the predominance of rare cancers in the adolescent population, and the small number of clinical trials for adolescents with rare cancers.
Information about these tumors may also be found in sources relevant to adults with cancer, such as Cancer of Unknown Primary Treatment.
Sources: Cancer of Unknown Primary Treatment
This page is made by Triangle. The reading above is selected source text, not a treatment recommendation, and it is not medical advice.
Source: Childhood Cancer of Unknown Primary (CUP) Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: August 13, 2024. Captured 2026-09-09.
Chemotherapy, targeted therapy, and radiation therapy may be used to treat childhood cancers of unknown primary sites. The appropriate and relevant treatments, according to the general category of carcinoma or sarcoma (depending on the histological findings, symptoms, and extent of tumor), are initiated as early as possible.[1]
Sources: 1
For more information, see Cancer of Unknown Primary Treatment.
Sources: Cancer of Unknown Primary Treatment
Source: Childhood Cancer of Unknown Primary (CUP) Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: August 13, 2024. Captured 2026-09-09.
Information about National Cancer Institute (NCI)–supported clinical trials can be found on the NCI website. For information about clinical trials sponsored by other organizations, see the ClinicalTrials.gov website.
Sources: NCI website · ClinicalTrials.gov website
Source: Childhood Carcinoma of Unknown Primary Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: January 12, 2024. Captured 2026-09-09.
When it is not known where the cancer first formed at diagnosis, adenocarcinomas, melanomas, and embryonal tumors (such as rhabdomyosarcoma or neuroblastoma) are tumor types that are often diagnosed later in children and adolescents.
Sources: adenocarcinomas · melanomas · embryonal tumors · rhabdomyosarcoma · neuroblastoma · adolescents
Source: Childhood Carcinoma of Unknown Primary Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: January 12, 2024. Captured 2026-09-09.
Source: Childhood Carcinoma of Unknown Primary Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: January 12, 2024. Captured 2026-09-09.
There are different types of treatment for children with carcinoma of unknown primary.
Children with carcinoma of unknown primary should have their treatment planned by a team of doctors who are experts in treating childhood cancer.
Three types of standard treatment are used:
Three types of standard treatment are used:
Radiation therapy
Chemotherapy
Targeted therapy
New types of treatment are being tested in clinical trials.
Treatment for childhood carcinoma of unknown primary may cause side effects.
Patients may want to think about taking part in a clinical trial.
Patients can enter clinical trials before, during, or after starting their cancer treatment.
Follow-up tests may be needed.
Source: Childhood Carcinoma of Unknown Primary Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: January 12, 2024. Captured 2026-09-09.
Some treatments are standard (the currently used treatment), and some are being tested in clinical trials. A treatment clinical trial is a research study meant to help improve current treatments or obtain information on new treatments for patients with cancer. When clinical trials show that a new treatment is better than the standard treatment, the new treatment may become the standard treatment.
Sources: standard · clinical trials · research study
Because cancer in children is rare, taking part in a clinical trial should be considered. Some clinical trials are open only to patients who have not started treatment.
Source: Childhood Carcinoma of Unknown Primary Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: January 12, 2024. Captured 2026-09-09.
Treatment will be overseen by a pediatric oncologist, a doctor who specializes in treating children with cancer. The pediatric oncologist works with other pediatric health professionals who are experts in treating children with cancer and who specialize in certain areas of medicine. This may include the following specialists and others:
Sources: pediatric oncologist · cancer · pediatric · medicine · specialists
Pediatrician.
Sources: Pediatrician
Radiation oncologist.
Sources: Radiation oncologist
Pathologist.
Sources: Pathologist
Social worker.
Sources: Social worker
Rehabilitation specialist.
Sources: Rehabilitation specialist
Psychologist.
Sources: Psychologist
Child-life specialist.
Sources: Child-life specialist
Source: Childhood Carcinoma of Unknown Primary Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: January 12, 2024. Captured 2026-09-09.
Source: Childhood Carcinoma of Unknown Primary Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: January 12, 2024. Captured 2026-09-09.
Radiation therapy is a cancer treatment that uses high-energy x-rays or other types of radiation to kill cancer cells or keep them from growing. External radiation therapy uses a machine outside the body to send radiation toward the area of the body with metastatic cancer.
Sources: Radiation therapy · x-rays · radiation · cells · External radiation therapy · metastatic
Source: Childhood Carcinoma of Unknown Primary Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: January 12, 2024. Captured 2026-09-09.
Chemotherapy is a cancer treatment that uses drugs to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. When chemotherapy is taken by mouth or injected into a vein or muscle, the drugs enter the bloodstream and can reach cancer cells throughout the body (systemic chemotherapy).
Sources: Chemotherapy · drugs · injected · vein · systemic chemotherapy
Source: Childhood Carcinoma of Unknown Primary Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: January 12, 2024. Captured 2026-09-09.
Targeted therapy is a treatment that uses drugs or other substances to identify and attack cancer cells.Targeted therapies usually cause less harm to normal cells than chemotherapy and radiation therapy do.
Sources: Targeted therapy
Source: Childhood Carcinoma of Unknown Primary Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: January 12, 2024. Captured 2026-09-09.
Information about clinical trials is available from the NCI website.
Sources: clinical trials · NCI website
Source: Childhood Carcinoma of Unknown Primary Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: January 12, 2024. Captured 2026-09-09.
To learn more about side effects that begin during treatment for cancer, visit Side Effects.
Sources: side effects · Side Effects
Source: Childhood Carcinoma of Unknown Primary Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: January 12, 2024. Captured 2026-09-09.
For some patients, taking part in a clinical trial may be the best treatment choice. Clinical trials are part of the cancer research process. Clinical trials are done to find out if new cancer treatments are safe and effective or better than the standard treatment.
Sources: clinical trial · standard treatment
Many of today's standard treatments for cancer are based on earlier clinical trials. Patients who take part in a clinical trial may receive the standard treatment or be among the first to receive a new treatment.
Patients who take part in clinical trials also help improve the way cancer will be treated in the future. Even when clinical trials do not lead to effective new treatments, they often answer important questions and help move research forward.
Source: Childhood Carcinoma of Unknown Primary Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: January 12, 2024. Captured 2026-09-09.
Some clinical trials only include patients who have not yet received treatment. Other trials test treatments for patients whose cancer has not gotten better. There are also clinical trials that test new ways to stop cancer from recurring (coming back) or reduce the side effects of cancer treatment.
Sources: side effects
Clinical trials are taking place in many parts of the country. Information about clinical trials supported by NCI can be found on NCI’s clinical trials search webpage. Clinical trials supported by other organizations can be found on the ClinicalTrials.gov website.
Sources: clinical trials search · ClinicalTrials.gov
Source: Childhood Carcinoma of Unknown Primary Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: January 12, 2024. Captured 2026-09-09.
As your child goes through treatment, they will have follow-up tests or check-ups. Some tests that were done to diagnose or stage the cancer may be repeated to see how well the treatment is working. Decisions about whether to continue, change, or stop treatment may be based on the results of these tests.
Some of the tests will continue to be done from time to time after treatment has ended. The results of these tests can show if your child's condition has changed or if the cancer has recurred (come back).
Source: Childhood Carcinoma of Unknown Primary Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: January 12, 2024. Captured 2026-09-09.
Treatment of newly diagnosed carcinoma of unknown primary (CUP) in children depends on the following:
Sources: diagnosed · carcinoma of unknown primary
What the cancer cells look like under a microscope.
Sources: cancer · cells · microscope
The child's age.
The results of tests and procedures.
Where the cancer has spread in the body.
For information about the treatments listed below, see the Treatment Option Overview section.
Sources: Treatment Option Overview
Treatment of newly diagnosed CUP in children may include the following:
Radiation therapy.
Sources: Radiation therapy
Chemotherapy.
Sources: Chemotherapy
Targeted therapy.
Sources: Targeted therapy
Sometimes childhood carcinoma of unknown primary can recur (come back) after treatment. If your child is diagnosed with a recurrent carcinoma of unknown primary, your child's doctor will work with you to plan treatment.
Use our clinical trial search to find NCI-supported cancer clinical trials that are accepting patients. You can search for trials based on the type of cancer, the age of the patient, and where the trials are being done. General information about clinical trials is also available.
Sources: clinical trial search · General information
Cancer of Unknown Primary (CUP) in children and adolescents